Showing results (391-400 of 446) with videos related to
Sort By:
Pageof 45
Plos One|December 11, 2020
Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver diseaseAli Bayoumi, Ismail Jalil, Mayada Metwally, et al.The American Journal of Gastroenterology|December 13, 2017
Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and OutcomeMaren H Harms, Willem J Lammers, Douglas Thorburn, et al.Clinical Nutrition ESPEN|February 27, 2026
Protective potential of minimally processed, plant-derived foods against steatotic liver disease in early adulthoodYasmina Tashkent, Jocelyn M Choo, Steven L Taylor, et al.Hepatology (Baltimore, Md.)|June 3, 2024
A randomized multicenter trial of a chronic disease management intervention for decompensated cirrhosis. The A ustra l ian L iver F a i lur e (ALFIE) trialAlan J Wigg, Sumudu Narayana, Richard J Woodman, et al.Journal of Hepatology|November 4, 2018
A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3'UTRMayada Metwally, Ali Bayoumi, Manuel Romero-Gomez, et al.The Medical Journal of Australia|July 28, 2025
Assessment of metabolic dysfunction-associated fatty liver disease in primary care: a consensus statement summaryLeon A Adams, William W Kemp, Kate R Muller, et al.Hepatology (Baltimore, Md.)|December 20, 2014
The impact of phlebotomy in nonalcoholic fatty liver disease: A prospective, randomized, controlled trialLeon A Adams, Darrell H Crawford, Katherine Stuart, et al.Journal of Hepatology|December 3, 2014
An extension of STARD statements for reporting diagnostic accuracy studies on liver fibrosis tests: the Liver-FibroSTARD standardsJérôme Boursier, Victor de Ledinghen, Thierry Poynard, et al.Gastroenterology|August 12, 2015
Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid TherapyWillem J Lammers, Gideon M Hirschfield, Christophe Corpechot, et al.Hepatology (Baltimore, Md.)|July 18, 2018
ADAPT: An Algorithm Incorporating PRO-C3 Accurately Identifies Patients With NAFLD and Advanced FibrosisSamuel J Daniels, Diana J Leeming, Mohammed Eslam, et al.Pageof 45